Position in OGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$6,093,000
+$5,026,876 QoQ
Shares Held
450,000
+528.5% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#70
of 626 holders
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alberta Investment Management Corp holds $61,935,280 across 2 Drug Manufacturers - General names. OGN ranks #2 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
442,000 | $55,842,280 | |
| 2 | OGN |
Organon & Co.
This page
|
450,000 | $6,093,000 |
All Filings in OGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,093,000 | 450,000 | Shares | Sole | 2026-08-06 | |
| 2025-03-31 | $1,066,124 | 71,600 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,068,272 | 71,600 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,369,708 | 71,600 | Shares | Sole | 2024-11-05 | |
| 2023-06-30 | $4,033,269 | 193,814 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $4,367,899 | 185,710 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,186,880 | 185,710 | Shares | Sole | 2023-02-14 | |
| 2021-06-30 | $580,477 | 19,183 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||